UK markets open in 3 hours 43 minutes

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
68.20-0.60 (-0.87%)
At close: 4:00PM EST

65.99 -2.21 (-3.24%)
After hours: 7:59PM EST

Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2019
30/09/2018
30/09/2017
Total revenue
163,592
168,796
16,142
31,408
Operating expenses
Research development
86,850
81,049
52,969
31,690
Selling general and administrative
31,206
26,556
19,110
32,023
Total operating expenses
118,201
107,605
72,079
68,404
Operating income or loss
45,392
61,191
-55,936
-36,996
Total other income/expenses net
-
-
439.634
2,203
Income before tax
53,437
68,148
-54,448
-34,378
Income tax expense
173.553
173.553
2.4
2.4
Income from continuing operations
53,264
67,975
-54,450
-34,380
Net income
53,264
67,975
-54,450
-34,380
Net income available to common shareholders
53,264
67,975
-54,450
-34,380
Basic EPS
-
0.72
-0.65
-0.47
Diluted EPS
-
0.69
-0.65
-0.47
Basic average shares
-
93,859
83,638
73,899
Diluted average shares
-
98,608
83,638
73,899
EBITDA
-
65,630
-51,237
-32,305